Jeffrey Brower, MD, PhD
About the founder

Jeffrey Brower, MD, PhD

Founder & Editor-in-Chief, CarcinoS
Adjunct Associate Professor, University of Wisconsin
Practicing oncologist, Radiation Oncology Associates (hybrid private–academic practice)

Why CarcinoS exists

Most oncologists don't need more to read. They need confidence that they haven't missed the few findings that could change how they treat patients. General-purpose AI tools don't solve that, and in literature surveillance they can invent papers that don't exist.

CarcinoS was built to work quietly in the background: surfacing what has changed, linking to the evidence, and staying out of the way the rest of the time.

Editorial background

Over the past ten years, Dr. Brower has held major editorial roles with oncology journals, educational resources and accrediting bodies. CarcinoS brings that same editorial discipline to the weekly literature.

C S
Carcino S

Editorial Framework

Carcino S is built on a deterministic ingestion pipeline. AI assists with synthesis. A practicing oncologist holds final editorial authority over every alert.

Step 01
Continuous Surveillance
Automated monitoring across major oncology sources, updated continuously.
  • NEJM, Lancet, JCO, JAMA Oncology
  • ASCO, ESMO, ASH proceedings
  • FDA & EMA regulatory releases
  • Preprint & early-access publications
Step 02
Impact Scoring
Each study is evaluated against a structured clinical relevance framework.
  • Overall survival benefit
  • FDA / regulatory approval
  • Phase III trial evidence
  • Biomarker-defined populations
  • Quality of life & safety data
Step 03
Tier Assignment
Studies are classified into one of three clearly defined tiers.
■■■
Practice-Impacting
Immediate clinical relevance
■■
Incremental
Important but not practice-changing
■
Horizon
Early signals worth monitoring
Get involvedInterested in the product, outreach or business side of building an oncology resource? There's room to get involved.
Learn more →
Request Access →